elevated heart rate tirzepatide Effects of on the Clinical Trajectory of Patients With Failure, Preserved Ejection Fraction, and Obesity Retatrutide Heart Rate Increase: Mechanism,

Safety data for Tirzepatide includes monitoring for pancreatitis, gallbladder disease, and kidney problems, while Survodutide's long-term safety profile remains unknown due to ongoing trial status

This pathway primarily influences insulin secretion and glucagon inhibition in pancreatic beta and alpha cells, respectively

It also reduces the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with type 2 diabetes and known heart disease, and decreases the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease

Clinical studies show that people typically lose around 2% of their body weight by the end of the first month, with more noticeable changessuch as improved appetite control and reduced cravingsemerging by the third month

Improved CV health was observed when using GLP-1 RA, with a reduction in dyslipidemia and arterial hypertension risk factors